| Literature DB >> 26490952 |
Jayanta Gupta1, Peter A Kanetsky2, Matthias Wuttke3, Anna Köttgen3, Franz Schaefer4, Craig S Wong5.
Abstract
The genome-wide association study (GWAS) has become an established scientific method that provides an unbiased screen for genetic loci potentially associated with phenotypes of clinical interest, such as chronic kidney disease (CKD). Thus, GWAS provides opportunities to gain new perspectives regarding the genetic architecture of CKD progression by identifying new candidate genes and targets for intervention. As such, it has become an important arm of translational science providing a complementary line of investigation to identify novel therapeutics to treat CKD. In this review, we describe the method and the challenges of performing GWAS in the pediatric CKD population. We also provide an overview of successful GWAS for kidney disease, and we discuss the established pediatric CKD cohorts in North America and Europe that are poised to identify genetic risk variants associated with CKD progression.Entities:
Keywords: Chronic kidney disease; Genetics; Genome-wide association study (GWAS); Pediatric; Translational medicine
Mesh:
Year: 2015 PMID: 26490952 PMCID: PMC5287054 DOI: 10.1007/s00467-015-3235-y
Source DB: PubMed Journal: Pediatr Nephrol ISSN: 0931-041X Impact factor: 3.714